Financial reports
10-Q
2021 Q1
Quarterly report
3 May 21
10-K/A
2020 FY
Annual report (amended)
30 Apr 21
10-K
2020 FY
Annual report
26 Feb 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
10-Q
2020 Q1
Quarterly report
11 May 20
10-K
2019 FY
Annual report
27 Feb 20
10-Q
2019 Q3
Quarterly report
6 Nov 19
10-Q
2019 Q2
Quarterly report
7 Aug 19
10-Q
2019 Q1
Quarterly report
8 May 19
Current reports
8-K
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
5 May 21
8-K
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
23 Apr 21
8-K
Other Events
20 Apr 21
8-K
Other Events
14 Apr 21
8-K
Other Events
23 Mar 21
8-K
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2020 Financial Results and Operational Progress
16 Feb 21
8-K
Other Events
3 Feb 21
8-K
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating
3 Feb 21
8-K
GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones
12 Jan 21
8-K
GW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results
3 Nov 20
Registration and prospectus
15-12B
Securities registration termination
17 May 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 May 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 May 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 May 21
POSASR
Automatic shelf registration (post-effective amendment)
5 May 21
25-NSE
Exchange delisting
5 May 21
S-8
Registration of securities for employees
27 May 20
S-3ASR
Automatic shelf registration
18 Jan 19
424B5
Prospectus supplement for primary offering
3 Oct 18
424B5
Prospectus supplement for primary offering
1 Oct 18
Proxies
DEFA14A
Additional proxy soliciting materials
20 Apr 21
DFAN14A
Additional proxy materials by non-management
20 Apr 21
DEFA14A
Additional proxy soliciting materials
14 Apr 21
DEFA14A
Additional proxy soliciting materials
25 Mar 21
DEFA14A
Additional proxy soliciting materials
24 Mar 21
DFAN14A
Additional proxy materials by non-management
23 Mar 21
DEFA14A
Additional proxy soliciting materials
23 Mar 21
DEFA14A
Additional proxy soliciting materials
15 Mar 21
DEFM14A
Proxy related to merger
15 Mar 21
PREM14A
Preliminary proxy related to merger
5 Mar 21
Other
CT ORDER
Confidential treatment order
21 Dec 17
CT ORDER
Confidential treatment order
22 Dec 16
CT ORDER
Confidential treatment order
16 Jun 16
CT ORDER
Confidential treatment order
4 Feb 15
EFFECT
Notice of effectiveness
8 Jan 14
CT ORDER
Confidential treatment order
8 Jan 14
CORRESP
Correspondence with SEC
6 Jan 14
CORRESP
Correspondence with SEC
6 Jan 14
UPLOAD
Letter from SEC
2 Jan 14
EFFECT
Notice of effectiveness
7 May 13
Ownership